NCT00772928 - Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ | Biotech Hunter

Enrollment

1,167

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

November 30, 2006

Conditions

DiphtheriaTetanusHaemophilus InfectionPertussisPolio

Interventions

BIOLOGICAL

Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®

0.5 mL, Intramuscular

BIOLOGICAL

Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®

0.5 mL, Intramuscular

Trial Locations (23)

11201

Brooklyn

15241

Pittsburgh

19401

Norristown

36106

Montgomery

40004

Bardstown

40202

Louisville

54601

La Crosse

64112

Kansas City

72205

Little Rock

72401

Jonesboro

72703

Fayetteville

76107

Fort Worth

78229

San Antonio

78745

Austin

San Antonio

84041

Layton

90274

Rolling Hills Estate

92708

Fountain Valley

94612

Oakland

98864

Vancouver

99220

Spokane

06360

Norwich

02115

Boston